| Newaygo Middle School Behavioral Health Services | |
|
850 76th St Rm 101g Newaygo MI 49337-7930 | |
| (231) 652-1285 | |
| (231) 745-2743 |
| Full Name | Newaygo Middle School Behavioral Health Services |
|---|---|
| Speciality | Clinic/Center |
| Location | 850 76th St Rm 101g, Newaygo, Michigan |
| Authorized Official Name and Position | Julie Tatko (CEO) |
| Authorized Official Contact | 2317452743 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Newaygo Middle School Behavioral Health Services 1615 Michigan Ave Baldwin MI 49304-7984 Ph: (231) 745-2743 | Newaygo Middle School Behavioral Health Services 850 76th St Rm 101g Newaygo MI 49337-7930 Ph: (231) 652-1285 |
| NPI Number | 1528627700 |
|---|---|
| Provider Enumeration Date | 06/11/2019 |
| Last Update Date | 11/12/2020 |
| Certification Date | 11/12/2020 |
| Medicare PECOS PAC ID | 1153215413 |
|---|---|
| Medicare Enrollment ID | O20191008000550 |
News Archive
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
New research has shown that older workers with obesity are at a higher risk of prolonged sickness absence or losing their jobs for health reasons than those of normal weight, with women affected significantly more than men.
Oncolytics Biotech Inc. today announced that it has entered into a commercial supply agreement with SAFC, a Division of Sigma-Aldrich Corporation, for the commercial manufacture of REOLYSIN, Oncolytics proprietary reovirus.
Contrary to the prevailing view, the hormone leptin, which is critical for normal food intake and metabolism, appears to regulate bone mass and suppress appetite by acting mainly through serotonin pathways in the brain, according to a recent study published in Cell by Yale School of Medicine researchers and colleagues at Columbia University. This new finding contradicts the view that leptin acts primarily in the hypothalamus.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528627700 | NPI | - | NPPES |
News Archive
Acorda Therapeutics, Inc. today announced that the Company has submitted applications to extend patent protection for AMPYRA™ (dalfampridine) Extended Release Tablets, 10 mg to the United States Patent and Trademark Office.
New research has shown that older workers with obesity are at a higher risk of prolonged sickness absence or losing their jobs for health reasons than those of normal weight, with women affected significantly more than men.
Oncolytics Biotech Inc. today announced that it has entered into a commercial supply agreement with SAFC, a Division of Sigma-Aldrich Corporation, for the commercial manufacture of REOLYSIN, Oncolytics proprietary reovirus.
Contrary to the prevailing view, the hormone leptin, which is critical for normal food intake and metabolism, appears to regulate bone mass and suppress appetite by acting mainly through serotonin pathways in the brain, according to a recent study published in Cell by Yale School of Medicine researchers and colleagues at Columbia University. This new finding contradicts the view that leptin acts primarily in the hypothalamus.
Eli Lilly and Company announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion for ixekizumab for the treatment of moderate-to-severe plaque psoriasis in adults in the European Union who are candidates for systemic therapy.
› Verified 7 days ago
Angela Vargas-avendano Msw Plc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 130 W Wood St, Newaygo, MI 49337 Phone: 231-206-6519 | |
Illuminate Counseling & Wellness Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 42 State Rd Ste A, Newaygo, MI 49337 Phone: 231-942-4673 | |
Jennifer Braman Msw Plc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 130 W Wood St, Newaygo, MI 49337 Phone: 231-206-6159 | |
Sunlight Counseling & Therapy Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1 W State Rd, Newaygo, MI 49337 Phone: 616-414-0879 | |
Arbor Circle Corporation Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 E 82nd St, Newaygo, MI 49337 Phone: 231-652-1780 Fax: 231-652-1786 | |
Jennifer Deja Msw Plc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 130 W Wood St, Newaygo, MI 49337 Phone: 231-206-6159 |